Sangani Hospitals Ltd IPO: Issue Details, Open/Close Date | Research 360 by Motilal Oswal
Back arrow

Sangani Hospital

CMP

44.50

-0.50 (-1.11%)

₹40

Offer Price

₹ 15.17 Cr

Issue Size

₹ 1,20,000

Min Investment

3,000

Lot size

Time Line

  • 04
    Aug 2023
    Open
  • 08
    Aug 2023
    Close
  • 11
    Aug 2023
    Finalisation of Basis of Allotment
  • 14
    Aug 2023
    Initiation of Refunds
  • 16
    Aug 2023
    Transfer of Shares to Demat Account
  • 17
    Aug 2023
    Listing Date

Objects of the Offer

  • Continue to strengthen healthcare services across other specialties.

  • Implement initiatives to improve operational efficiencies.

  • Continue to grow its ancillary businesses.

  • Digital healthcare initiatives to address patient convenience, operational efficiencies and expand reach.

Products & Services

  • Sangani Hospitals Limited is a multi-speciality healthcare provider operating in Keshod and Veraval region of Gujarat with a combined bed capacity of 68 beds.

Strengths

  • Doctor-led` hospitals driven by skilled and experienced doctors in the healthcare space.

  • Focus on under-served areas with dense population.

  • Growth opportunities in existing facilities and diversification into new services

  • Ability to attract quality doctors, nurses, paramedical, and other staff.

Risks

  • A significant portion of the revenue is currently generated from two hospitals Sangani Hospital, Keshod and Sangani Super Speciality Hospital, Veraval. Further, both the hospitals are located in the state of Gujarat. Any material impact on the revenue from these hospitals will impact its business, prospects, financial condition and results of operations significantly.

  • In past, the hospital has undertaken and may continue to undertake strategic investments, acquisitions and mergers in the future, which may be difficult to integrate and manage. Its future success depends on the hospital ability to achieve and manage growth, whether through internal growth or strategic acquisitions.

  • The Hospital is significantly dependent on the Promoters, Dr. Ajaykumar Sangani, Dr. Rajeshkumar Sangani & Dr. Vaishali Sangani, and any loss of their services could adversely affect its business and results of operations.

  • Discontinuation of association by doctors and other healthcare professionals with the hospitals for any reason, and its inability to retain them may adversely affect of the business and results of operations.

  • Delay in receipt of payment from the patients / customers and government bodies may affect its cash flows, which may, in turn affect the Hospital financial condition and results of operations.

Company Promoters

Promoters Holding

Issue For IPO
99.60%
Pre Holding

99.60%

Post Holding

-

Top Promoters Holding

Financials

All values in Cr

Mar-2022 Mar-2023 Mar-2023 3-Yr trend
Revenue 4.20 (-) 15.67 (273.10%) 12.91 (-)
Gross Profit 4.20 (-) 15.67 (273.10%) 12.91 (-)
Net Income 4.20 (-) 15.67 (273.10%) 12.91 (-)
Assets 4.20 (-) 15.67 (273.10%) 12.91 (-)
Liabilities 4.20 (-) 15.67 (273.10%) 12.91 (-)

Peers

Company Name Revenue (Cr) Net Profit (Cr) Assets (Cr) Liabilities (Cr) ROE EPS BVPS Current Ratio Debt to Assets
Sangani Hospitals Ltd 15.67 1.48 18.12 0.14 12.91 1.49 18.00 5.18 0.01
Artemis Medicare Services Ltd 737.43 38.60 904.95 904.95 11.49 2.79 25.37 4.26 0.72
Lotus Eye Hospital & Institute Ltd 47.04 4.08 63.19 63.19 7.08 1.96 27.69 6.45 0.00

Book Running Managers

  • Unistone Capital Pvt Ltd

Registrar & Transfer Agent

Bigshare Services Pvt Ltd

Office No 56-2,
Pinnacle Busine.Park,
Mahakali Caves Road - Mumbai - 400093
Phone : 91-22-62638200 Fax: 91-22-63638299

Company Contact Information

Sainath Society Opp S.T.KSD T,
Taluka Keshod,
Junagadh - 362220
Phone : 02871-23 5900 Email : cs@sanganihospitals.com www.sanganihospitals.com

Offer Related Information

Initial public offer of 37,92,000* equity shares of face value of Rs. 10 each ("Equity Shares") of Sangani Hospitals Limited ("Company") for cash at a price of Rs. 40 per equity share (including a share premium of Rs. 30 per equity share) ("Issue Price") aggregating to Rs. 15.17 crores of which to 1,92,000 equity shares of face value of Rs. 10 each for cash at a price of Rs. 40 per equity share including a share premium of Rs. 30 per equity share aggregating to Rs. 0.77 crores will be... More

Take your research to the next level.
Login now to unlock Exclusive Features!

Take your research to the next level.
Login now to unlock Exclusive Features!

Download Our App On: